Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 33

Results For "neuro"

549 News Found

100 bedded Yoga & Naturopathy Hospital to come up in Dibrugarh
News | January 30, 2024

100 bedded Yoga & Naturopathy Hospital to come up in Dibrugarh

Union Ayush Minister with Assam Chief Minister lays foundation stone for Central Research Institute of Yoga & Naturopathy


Health Minister Mandaviya inaugurates super specialty block at GSVM Medical College in UP
Healthcare | January 25, 2024

Health Minister Mandaviya inaugurates super specialty block at GSVM Medical College in UP

Dr. Mandaviya also laid the foundation stone for an All India Institute of Speech and Hearing (AIISH) Satellite Centre in Kanpur


ImmunoBrain Checkpoint appoints Dr. Sanjay Keswani as CEO
People | January 24, 2024

ImmunoBrain Checkpoint appoints Dr. Sanjay Keswani as CEO

He is a former Neurology faculty member at The Johns Hopkins Hospital and an elected Fellow of the Royal College of Physicians, United Kingdom


EMA grants ODD to GC Biopharma's treatment for Sanfilippo Syndrome
Drug Approval | January 23, 2024

EMA grants ODD to GC Biopharma's treatment for Sanfilippo Syndrome

GC1130A has previously achieved notable milestones by securing both RPDD and ODD from the U.S. FDA in January 2023


AbbVie launches Produodopa for treatment of parkinson's disease in EU
News | January 20, 2024

AbbVie launches Produodopa for treatment of parkinson's disease in EU

Produodopa is the first-and-only subcutaneous 24-hour infusion of levodopa-based therapy for the treatment of severe motor fluctuations


NITI Aayog organises workshop on ‘Strengthening Mental Health Services and Care in India’
Policy | January 12, 2024

NITI Aayog organises workshop on ‘Strengthening Mental Health Services and Care in India’

The workshop was conducted as a part of the NITI–State workshop series


Merck to acquire Harpoon Therapeutics for US$ 680 million
News | January 10, 2024

Merck to acquire Harpoon Therapeutics for US$ 680 million

Acquisition includes HPN328, an investigational delta-like ligand 3 (DLL3) targeting T-cell engager being evaluated in certain patients with small cell lung cancer and neuroendocrine tumors


USFDA accepts sBLA of TIVDAK for priority review for patients with metastatic cervical cancer
Drug Approval | January 10, 2024

USFDA accepts sBLA of TIVDAK for priority review for patients with metastatic cervical cancer

Submission based on positive results from global phase 3 study demonstrating overall survival benefit of TIVDAK over chemotherapy


Medway Hospitals raises US$5 million in a financing round led by Kyra Ventures
News | January 04, 2024

Medway Hospitals raises US$5 million in a financing round led by Kyra Ventures

Medway setup a state-of-the-art Heart Institute in Chennai


Cell and gene therapy will be top industry trend for pharma in 2024, finds GlobalData
News | January 02, 2024

Cell and gene therapy will be top industry trend for pharma in 2024, finds GlobalData

The survey data presented in “The State of the Biopharmaceutical Industry 2024” report reveals that N=21 (18%) of industry professionals were convinced that CGT will dominate as the most important trend in pharma next year